• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于经导管主动脉瓣置换术的脑保护装置

Cerebral protection devices for transcatheter aortic valve replacement.

作者信息

Jobanputra Yash, Jones Brandon M, Mohananey Divyanshu, Fatima Benish, Kandregula Krishna, Kapadia Samir R

机构信息

a Department of Cardiovascular Medicine , Heart and Vascular Institute, Cleveland Clinic , Cleveland , OH , USA.

出版信息

Expert Rev Med Devices. 2017 Jul;14(7):529-543. doi: 10.1080/17434440.2017.1347038. Epub 2017 Jul 13.

DOI:10.1080/17434440.2017.1347038
PMID:28658982
Abstract

Stroke is a devastating, potential complication of any cardiovascular procedure including transcatheter aortic valve implantation (TAVI). Even clinically silent lesions as detected by magnetic resonance imaging have been associated with poor long-term cognitive outcomes. As a result, extensive efforts have been focused on developing stroke preventative strategies including the development of novel embolic protection devices. These devices aim to reduce this risk by capturing or deflecting emboli away from the cerebral circulation. Areas covered: This review provides an insight into the incidence and mechanisms of neurologic events during TAVI, explores the design features and initial human experience of each of the cerebral embolic protection devices that have been used during TAVI, and carefully explains the major clinical trials of each of these devices with a focus on safety, efficacy and other reported outcomes. Expert commentary: The potential benefit of neuroprotection cannot be ignored as TAVI widens its scope to include younger and lower-risk patients wherein preventing a procedure related cerebral injury would potentially prevent long-term morbidity and mortality.

摘要

中风是包括经导管主动脉瓣植入术(TAVI)在内的任何心血管手术的一种严重的潜在并发症。即使是磁共振成像检测到的临床无症状病变也与长期认知不良后果相关。因此,大量努力集中在制定中风预防策略,包括开发新型栓塞保护装置。这些装置旨在通过捕获或使栓子偏离脑循环来降低这种风险。涵盖领域:本综述深入探讨了TAVI期间神经事件的发生率和机制,探讨了TAVI期间使用的每种脑栓塞保护装置的设计特点和初步人体经验,并详细解释了这些装置各自的主要临床试验,重点关注安全性、有效性和其他报告结果。专家评论:随着TAVI扩大其适用范围,纳入更年轻和风险更低的患者,神经保护的潜在益处不容忽视,在这些患者中预防与手术相关的脑损伤可能会预防长期发病和死亡。

相似文献

1
Cerebral protection devices for transcatheter aortic valve replacement.用于经导管主动脉瓣置换术的脑保护装置
Expert Rev Med Devices. 2017 Jul;14(7):529-543. doi: 10.1080/17434440.2017.1347038. Epub 2017 Jul 13.
2
Cerebral protection devices during transcatheter aortic valve implantation.经导管主动脉瓣植入术中的脑保护装置
Trends Cardiovasc Med. 2018 Aug;28(6):412-418. doi: 10.1016/j.tcm.2018.01.007. Epub 2018 Feb 2.
3
Cerebral embolic protection systems for transcatheter aortic valve replacement.用于经导管主动脉瓣置换术的脑栓塞保护系统。
J Interv Cardiol. 2018 Dec;31(6):891-898. doi: 10.1111/joic.12573. Epub 2018 Nov 22.
4
Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Implantation: Systematic Review and Meta-Analysis.经导管主动脉瓣植入术中的脑栓塞保护装置:系统评价与荟萃分析
Stroke. 2017 May;48(5):1306-1315. doi: 10.1161/STROKEAHA.116.015915. Epub 2017 Apr 14.
5
Cerebral embolic protection devices during transcatheter aortic valve implantation, the current state of the art.经导管主动脉瓣植入术中的脑栓塞保护装置,当前技术水平
Acta Cardiol. 2022 May;77(3):196-203. doi: 10.1080/00015385.2021.1909276. Epub 2021 Apr 8.
6
Protection from Cerebral Embolic Events During Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术期间预防脑栓塞事件
Curr Cardiol Rep. 2016 Feb;18(2):16. doi: 10.1007/s11886-015-0692-7.
7
First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions.经导管主动脉瓣介入治疗中新型栓塞转向装置的首例人体应用经验。
EuroIntervention. 2012 May 15;8(1):51-6. doi: 10.4244/EIJV8I1A9.
8
Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.经导管主动脉瓣置换术中脑保护显著降低死亡率和卒率,优于无保护手术。
JACC Cardiovasc Interv. 2017 Nov 27;10(22):2297-2303. doi: 10.1016/j.jcin.2017.06.037. Epub 2017 Sep 13.
9
First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation.首例新型栓塞保护装置在经导管主动脉瓣植入术中的应用。
EuroIntervention. 2012 May 15;8(1):43-50. doi: 10.4244/EIJV8I1A8.
10
Cerebral embolic protection in patients undergoing transcatheter aortic valve implantation: Recent advances.经导管主动脉瓣植入术中脑栓塞保护:最新进展。
Kardiol Pol. 2022;80(6):644-650. doi: 10.33963/KP.a2022.0118. Epub 2022 May 6.

引用本文的文献

1
Cerebral embolic protection during transcatheter aortic valve replacement: a systematic review and meta-analysis of propensity score matched and randomized controlled trials using the Sentinel cerebral embolic protection device.经导管主动脉瓣置换术中的脑栓塞保护:使用 Sentinel 脑栓塞保护装置的倾向评分匹配和随机对照试验的系统评价和荟萃分析。
BMC Cardiovasc Disord. 2023 Jun 17;23(1):306. doi: 10.1186/s12872-023-03338-0.
2
Percutaneous Thrombus Removal in COVID-19-Infected Patient with Pulmonary Embolism.COVID-19 感染合并肺栓塞患者的经皮血栓清除术。
Methodist Debakey Cardiovasc J. 2021 Jul 15;17(2):e33-e36. doi: 10.14797/UUTH5836. eCollection 2021.
3
Patient-specific registration of 3D CT angiography (CTA) with X-ray fluoroscopy for image fusion during transcatheter aortic valve implantation (TAVI) increases performance of the procedure.
将 3D CT 血管造影 (CTA) 与 X 射线透视图像进行患者特定配准,以实现经导管主动脉瓣植入术 (TAVI) 期间的图像融合,可提高手术效果。
Clin Res Cardiol. 2018 Jun;107(6):507-516. doi: 10.1007/s00392-018-1212-8. Epub 2018 Feb 16.